Organoids-on-chips

Strengthen efficacy and safety evidence using relevant preclinical models and translational data.

Organoid-on-chip microfluidic device — CEA
Organoid-on-chip microfluidic device — CEA
01Carnot instituteCEA-Leti
02Development stageCMC / process / GMP readiness
03Main expertiseMedical devices
04Relevant fieldsOncology, Metabolic diseases / diabetes

Offer overview

What this offer helps you achieve

Strengthen efficacy and safety evidence using relevant preclinical models and translational data.

Scientific and technical scope

Organoids-on-chips: mimicking human organs to improve treatments CEA-Leti designs and creates microfluidic components, biocompatible materials to host and feed the cells, advanced sensors and lens-free imaging systems to observe them. Research areas are: Growth, vascularization and immunocompetence of organoids on microfluidic components Studies of organoids-on-chip functionality using dedicated sensors Monitoring with lens-free imaging, algorithms to interpret results Industrial-scale manufacturing of microfluidic components
01

Capabilities mobilised

Therapeutic areasValidation using preclinical modelsMedical devicesBiotesting
02

Application fields

OncologyMetabolic diseases / diabetes
Illustration of a vascularized organoid on a microfluidic chip
Organoid-on-chip illustration — CEA

Discuss this offer

Could this capability strengthen your R&D programme?

Present your scientific, technical or clinical need and identify the most relevant route to collaboration.